X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (40) 40
male (28) 28
female (27) 27
index medicus (26) 26
middle aged (23) 23
aged (18) 18
cardiac & cardiovascular systems (17) 17
cardiogenic shock (13) 13
myocardial infarction - complications (12) 12
cardiology (11) 11
early revascularization (10) 10
mortality (10) 10
myocardial infarction (10) 10
percutaneous coronary intervention (10) 10
shock, cardiogenic - etiology (10) 10
critical care medicine (9) 9
treatment outcome (9) 9
trial (9) 9
adult (8) 8
aged, 80 and over (8) 8
medicine & public health (8) 8
medicine, general & internal (8) 8
abridged index medicus (7) 7
acute myocardial-infarction (7) 7
angioplasty (7) 7
animals (7) 7
coronary vessels (7) 7
electrocardiography (7) 7
acute myocardial infarction (6) 6
levosimendan (6) 6
multiple organ dysfunction syndrome (6) 6
prospective studies (6) 6
randomized controlled trials as topic (6) 6
sepsis (6) 6
shock, cardiogenic - drug therapy (6) 6
shock, cardiogenic - therapy (6) 6
time factors (6) 6
cardiotonic agents - therapeutic use (5) 5
cardiovascular (5) 5
drug therapy (5) 5
heart attacks (5) 5
hemodynamics - drug effects (5) 5
internal medicine (5) 5
prognosis (5) 5
reperfusion (5) 5
risk factors (5) 5
shock, cardiogenic - mortality (5) 5
survival (5) 5
administration, oral (4) 4
angioplasty, balloon, coronary (4) 4
aortic counterpulsation (4) 4
calcium sensitizer (4) 4
cardiac patients (4) 4
cardiopulmonary bypass (4) 4
cytokines (4) 4
dobutamine (4) 4
heart failure (4) 4
heart-failure (4) 4
heart-rate-variability (4) 4
hydrazones - therapeutic use (4) 4
inflammation (4) 4
intra-aortic balloon pumping - methods (4) 4
life sciences (4) 4
management (4) 4
myocardial infarction - mortality (4) 4
myocardial infarction - therapy (4) 4
platelet aggregation inhibitors - administration & dosage (4) 4
pyridazines - therapeutic use (4) 4
registry (4) 4
shock (4) 4
swine (4) 4
thrombosis (4) 4
age factors (3) 3
analysis (3) 3
angioplasty, balloon, coronary - adverse effects (3) 3
association (3) 3
autonomic nervous system - physiopathology (3) 3
cardiac pacing, artificial - methods (3) 3
cardiotonic agents - pharmacology (3) 3
cardiovascular diseases (3) 3
care and treatment (3) 3
clinical trials (3) 3
complications (3) 3
coronary angiography (3) 3
diagnosis, differential (3) 3
dobutamine - therapeutic use (3) 3
dose-response relationship, drug (3) 3
double-blind (3) 3
dysfunction (3) 3
electrodes, implanted (3) 3
emergency medicine (3) 3
enoximone - therapeutic use (3) 3
heart attack (3) 3
heart failure - mortality (3) 3
heart rate variability (3) 3
human health and pathology (3) 3
hydrazones - pharmacology (3) 3
iabp (3) 3
infusions, intravenous (3) 3
intraaortic balloon counterpulsation (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cochrane Database of Systematic Reviews, ISSN 1465-1858, 11/2016, Volume 2016, Issue 11
Journal Article
The Lancet, ISSN 0140-6736, 09/2018, Volume 392, Issue 10152, pp. 1047 - 1057
Journal Article
Expert Review of Cardiovascular Therapy, ISSN 1477-9072, 02/2018, Volume 16, Issue 2, pp. 99 - 112
Introduction: About 5% of patients with myocardial infarction suffer from cardiogenic shock as a complication, with a mortality of ≥30%. Primary percutaneous... 
percutaneous coronary intervention | IABP | Acute heart failure | myocardial infarction | mechanical cardiac support | IABP-SHOCK trial | IABP-SHOCK II trial | cardiogenic shock | multiple organ dysfunction syndrome
Journal Article
American Heart Journal, ISSN 0002-8703, 2010, Volume 159, Issue 4, pp. 547 - 554
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 01/2018, Volume 2018, Issue 1, p. CD009669
Journal Article
Critical Care Medicine, ISSN 0090-3493, 01/2010, Volume 38, Issue 1, pp. 152 - 160
OBJECTIVE:Patients undergoing percutaneous coronary intervention (PCI) for acute myocardial infarction with cardiogenic shock (CS) are often treated with... 
Myocardial infarction | Shock | Transluminal | Systemic inflammatory response syndrome | Cardiogenic | Angioplasty | Acute Physiology and Chronic Health Evaluation | Intra-aortic balloon pump | Percutaneous coronary | intra-aortic balloon pump | REVASCULARIZATION | myocardial infarction | shock | percutaneous coronary | NECROSIS-FACTOR-ALPHA | ORGAN FAILURE | NATRIURETIC PEPTIDE | NATIONAL REGISTRY | PROGNOSTIC VALUE | systemic inflammatory response syndrome | ACUTE HEART-FAILURE | cardiogenic | HIGH-RISK | SEPTIC SHOCK | transluminal | PRIMARY ANGIOPLASTY | angioplasty | CRITICAL CARE MEDICINE | Myocardial Infarction - mortality | Prospective Studies | Age Factors | Follow-Up Studies | Humans | Middle Aged | Shock, Cardiogenic - mortality | Male | Counterpulsation - methods | Critical Illness - mortality | Aged, 80 and over | Electrocardiography | Adult | Female | Myocardial Infarction - diagnosis | Myocardial Infarction - surgery | Intra-Aortic Balloon Pumping - methods | Intensive Care Units | Shock, Cardiogenic - diagnosis | Hospital Mortality | Risk Assessment | Shock, Cardiogenic - complications | Probability | Treatment Outcome | Combined Modality Therapy | Shock, Cardiogenic - surgery | Coronary Angiography | Myocardial Infarction - complications | Multiple Organ Failure - prevention & control | Sex Factors | Survival Analysis | Critical Illness - therapy | Aged | APACHE
Journal Article
Journal Article
Expert review of cardiovascular therapy, 01/2018
About 5% of patients with myocardial infarction suffer from cardiogenic shock as a complication, with a mortality of ≥30%. Primary percutaneous coronary... 
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 12/2017, Volume 377, Issue 25, pp. 2419 - 2432
Journal Article